MADISON, Wis.--(BUSINESS WIRE)--A new agreement between Promega Corporation and the RNA & Formulation Core at the University of British Columbia will enable the facility to manufacture and distribute ...
LNP as the novel drug delivery system enhancing mRNA therapeutic efficacy has been proved for its delivery ability. This review provides valuable insights into the current state-of-the-art of LNP mRNA ...
From vaccines to personalized cancer therapies, scientists are studying the use of mRNA across many clinical applications. However, there are several factors that are unique to mRNA drug product ...
Messenger RNA (mRNA) therapeutics have moved from a promising idea to clinical reality, accelerating vaccine development and opening new paths for protein replacement, immuno-oncology, and gene ...
Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...